QCM
VKTX icon

Quantinno Capital Management’s Viking Therapeutics VKTX Stock Holding History

Quantinno Capital Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Buy
59,008
+17,926
+44% +$579K ﹤0.01% 1853
2026
Q1 		$1.34M Buy
41,082
+6,688
+19% +$215K ﹤0.01% 1928
2025
Q4 		$1.21M Buy
34,394
+3,387
+11% +$120K ﹤0.01% 1652
2025
Q3 		$815K Buy
31,007
+22,710
+274% +$678K ﹤0.01% 1617
2025
Q2 		$220K Buy
+8,297
New +$218K ﹤0.01% 2282

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Quantinno Capital Management's VKTX Position: Q2 2026 in Review

Quantinno Capital Management increased its Viking Therapeutics (VKTX) stake by 44% in Q2 2026, buying an estimated $579K and bringing the position to 59,008 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1853.

Quantinno Capital Management first reported a position in VKTX in Q2 2025 and has held it in 5 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Quantinno Capital Management held 59,008 shares of Viking Therapeutics worth $2.3M as of Q2 2026.
  • Quantinno Capital Management bought 17,926 Viking Therapeutics shares in Q2 2026, an estimated $579K.
  • Viking Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1853 holding.
  • Quantinno Capital Management first reported a position in Viking Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.